ВОЗДЕЙСТВИЕ ЭКСТРАКОРПОРАЛЬНОЙ ГЕМОСОРБЦИИ НА ЭЛИМИНАЦИЮ АНТИБАКТЕРИАЛЬНЫХ ПРЕПАРАТОВ ПРИ СЕПСИСЕ

  • Р. Э. Якубцевич УО "Гродненский государственный медицинский университет", Гродно, Беларусь https://orcid.org/0000-0002-8699-8216
  • Н. В. Белявский Гродненская университетская клиника, Гродно, Беларусь https://orcid.org/0000-0003-0452-8876
Ключевые слова: сепсис, гемосорбция, CytoSorb, Toraymyxin, антибактериальные препараты

Аннотация

Введение. Сепсис и септический шок составляют весомую долю причин смертельных исходов в отделениях интенсивной терапии. Гемосорбция в сочетании со стандартной терапией сепсиса уменьшает смертность в среднем на 5-7%, значительно снижает потребность пациентов в вазопрессорной поддержке.

Цель исследования. Изучить доступные в литературе данные о воздействии гемосорбции на динамику уровней антибиотиков в плазме крови пациентов.

Материал и методы. Проанализированы результаты более 20 исследований разных гемосорбентов в терапии сепсиса.

Результаты. Получены данные о значительном влиянии сорбентов CytoSorb и Toraymyxin B на фармако- кинетику ряда антибиотиков. В отношении белорусских сорбентов «Протеазосорб» и «ЛПС-гемо» данные отсутствуют.

Выводы. Степень элиминации антибактериальных препаратов во время гемосорбции зависит от конкретных особенностей каждого сорбента. Необходимо тщательно изучить все возможные побочные эффекты для максимально эффективного применения гемосорбции в терапии сепсиса.

Литература

Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001;29(7):1303- 1310. https://doi.org/10.1097/00003246-200107000-00002.

Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis inthe United States. Crit. Care Med. 2013;41(5):1167‐1174. https://doi.org/10.1097/CCM.0b013e31827c09f8.

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801‐810. https://doi.org/10.1001/jama.2016.0287.

Zanotti S, Kumar A, Kumar A. Cytokine modulation in sepsis and septic shock. Expert OpinInvestig. Drugs. 2002;11(8):1061‐1075. https://doi.org/10.1517/13543784.11.8.1061.

Hoffman WD, Natanson C. Endotoxin in septic shock. Anesth. Analg. 1993;77(3):613‐624. https://doi.org/10.1213/00000539-199309000-00032.

Monard C, Rimmelé T, Ronco C. Extracorporeal Blood Purification Therapies for Sepsis. Blood Purif. 2019;47(Suppl 3):1-14. https://doi.org/10.1159/000499520.

Yakubtsevich RE, Spas VV, Shapel IA, Kuznetsov OYe. Vozmozhnosti jeliminacii vospalitelnyh mediatorov pri sepsise s pomoshhju sorbcionnyh metodov detoksikacii [Possibilities of eliminating inflammatory mediators in sepsis by means of sorption detoxification methods]. Anesteziologija i reanimatologija. 2008(6):55-7. (Russian).

Ankawi G, Neri M, Zhang J, Breglia A, Ricci Z, Ronco C. Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purificationtherapy: the promises and the pitfalls. Crit. Care. 2018;22(1):262. https://doi.org/10.1186/s13054-018-2181-z.

Gaieski DF, Mikkelsen ME, Band RA, Pines JM, Massone R, Furia FF, Shofer FS, Goyal M. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit. Care Med. 2010;38(4):1045- 1053. https://doi.org/10.1097/CCM.0b013e3181cc4824.

Friesecke S, Stecher SS, Gross S, Felix SB, Nierhaus А. Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study. J. Artif. Organs. 2017;20(3):252-259. https://doi.org/10.1007/ s10047-017-0967-4.

Kogelmann K, Jarczak D, Scheller M, Drüner M. Hemoadsorption by CytoSorb in septic patients: a case series. Crit. Care. 2017;21(1):1-10. https://doi.org/10.1186/s13054- 017-1662-9.

Hawchar F, László I, Öveges N, Trásy D, Ondrik Z, Molnar Z. Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study. J. Crit. Care. 2019;49:172-178. https://doi.org/10.1016/j. jcrc.2018.11.003.

König C, Röhr AC, Frey OR, Brinkmann A, Roberts JA, Wichmann D, Braune S, Kluge S, Nierhaus A. In vitro re- moval of anti-infective agents by a novel cytokine adsorbent system. Int. J. Artif. Organs. 2019;42(2):57-64. https://doi.org/10.1177/0391398818812601.

Dimski T, Brandenburger T, MacKenzie C, Kindgen-Milles D. Elimination of glycopeptide antibiotics by cytokine hemoadsorption in patients with septic shock: A study of three cases. Int. J. Artif. Organs. 2020;43(12):753-757. https://doi.org/10.1177/0391398820917151.

Poli EC, Simoni C, André P, Buclin T, Longchamp D, Perez MH, Ferry T, Schneider AG. Clindamycin clearance during Cytosorb® hemoadsorption: A case report and pharmacokinetic study. Int. J. Artif. Organs. 2019;42(5):258- 262. https://doi.org/10.1177/0391398819831303.

Terayama T, Yamakawa K, Umemura Y, Aihara M, Fujimi S. Polymyxin B Hemoperfusion for Sepsis and Septic Shock: A Systematic Review and Meta-Analysis. Surg. Infect. (Larchmt). 2017;18(3):225-233. https://doi.org/10.1089/ sur.2016.168.

Rachoin JS, Foster D, Giese R, Weisberg LS, Klein DJ. Importance of Endotoxin Clearance in Endotoxemic Septic Shock: An Analysis Fromthe Evaluating Use of Polymyxin B Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemic Septic Shock (EUPHRATES) Trial. Crit. Care Explor. 2020;24;2(2):e0083. https://doi.org/10.1097/CCE.0000000000000083.

Shimokawa K, Takakuwa R, Taya K, Wada Y, Yamazaki N, Murata M, Hirata K, Masuno T, Yokota H, Ishii F. Adsorption of various antimicrobial agents to endotoxin removal polymyxin-B immobilized fiber (Toraymyxin®). Colloids Surf. B Biointerfaces. 2012;90:58-61. https://doi.org/10.1016/j.colsurfb.2011.09.046.

Shimokawa K, Takakuwa R, Wada Y, Yamazaki N, Ishii F. Adsorption of various antimicrobial agents to endotoxin removal polymyxin-B immobilized fiber (Toraymyxin®). Part 2: Adsorption of two drugs to Toraymyxin PMX-20R cartridges. Colloids Surf. B Biointerfaces. 2013;101:350- 352. https://doi.org/10.1016/j.colsurfb.2012.06.032.

Singhan W, Vadcharavivad S, Areepium N, Wittayalertpanya S, Chaijamorn W, Srisawat N. The effect of direct hemoperfusion with polymyxin B immobilized cartridge on meropenem in critically ill patients requiring renal support. J. Crit. Care. 2019;51:71-76. https://doi.org/10.1016/j.jcrc.2019.02.007.

Yakubtsevich RE, Spas VV, Maksimenko AV, Anisim RA, Toryanik NYe, Borodavko ON, Yanulevich TE. Vozmozhnosti jeliminacii citokinov u bolnyh sepsisom s pomoshhju jekstrakorporalnyh metodov ochishhenija krovi. Zhurnal Grodnenskogo gosudarstvennogo medicinskogo universiteta [Journal of the Grodno State Medical University]. 2008;3(23);88-90. (Russian).

Yakubchevich RE, Predko BA, Spas VV, Savostianik SA. Metody jekstrakorporalnoj gemokorrekcii i ih vlijanie na produkty mikrobnogo metabolizma u pacientov s sepsisom [Extracorporeal blood correction methods and their impact on products of microbial metabolism in patients with sepsis]. Anesteziologija i reanimatologija. 2015;60(5):67-70. (Russian).

Predko VA, Yakubtsevich RE, Spas VV, Stepuro II, Shapel IA, Lazovskaya MV. Izmenenie svjazyvajushhih svojstv syvorotochnogo albumina u pacientov s sepsisom pri provedenii jekstrakorporalnoj detoksikacii. Novosti hirurgii. [Surgery news]. 2009;17(2):83-90. (Russian).

Sergienko VK, Kazhina VA, Yakubtsevich RE, Spas VV, Klochko AI, Yagovdik IN. Retrospektivnyj analiz jeffektivnosti biospecificheskoj gemoperfuzii pri gnojno-septicheskoj patologii u detej [Retrospective analysis of the effectiveness of biospesific hemoperfusion during puru- lent-septic diseases in children]. Zhurnal Grodnenskogo gosudarstvennogo medicinskogo universiteta [Journal of the Grodno State Medical University]. 2012;(2):41-43. (Russian).

Yakubtsevich RE, Belyavsky NV, Glazev AA, Klisa SD. Dinamika urovnej nezamenimyh aminokislot v plazme krovi pacientov s sepsisom na fone primenenija metodov jekstrakorporalnoj detoksikacii [Dynamics of essential amino acids plasma levels in patients with sepsis treated by the extracorporeal blood purification methods]. Izvestija Nacionalnoj akademii nauk Belarusi. Serija medicinskih nauk [Proceedings of the National Academy of Sciences of Belarus. Medical series]. 2020;17(1):64-69. https://doi.org/10.29235/1814-6023-2020-17-1-64-69. (Russian).

Khoroshilov SYe, Karpun NA, Polovnikov SG, Nikulin AV, Kuzovlev AN. Selektivnaja gemosorbcija jendotoksina v lechenii abdominalnogo sepsisa [Selective hemosorption of endotoxin in the treatment of abdominal sepsis]. Obshhaja reanimatologija [General Reanimatology]. 2009;5(6):83-87. (Russian).

Bovkun IV, Gаvrilovа EG, Sokolov DV, Shlyk IV. Opyt primenenija selektivnoj LPS-sorbcii v kompleksnoj terapii bolnyh s gramotricatelnym sepsisom. Vestnik anesteziologii i reanimatologii. 2017;14(3):68-73. https://doi.org/10.21292/2078-5658-2017-14-3-68-73. (Russian).

Yarustovsky МB, Abramyan MV, Soldatkina AO, Komardina EV, Nazarov EI, Plyushch MG, Rogalskaya EA. Pervyj opyt primenenija selektivnoj LPS-adsorbcii v kompleksnoj intensivnoj terapii detej s gramotricatelnym sepsisom posle kardiohirurgicheskih operacij [Preliminary report regarding the use of LPS-adsorption in complex intensive therapy for children with gram-negative sepsis after heart surgery]. Anesteziologija i reanimatologija. 2017;62(5):376-381. https://doi.org/10.18821/0201-7563-2017-62-5-376-381. (Russian).

Tretjak DS, Gapanovich VN, Kirkovskij VV, Starostin AV. Issledovanie gemosovmestimosti i sorbcionnoj emkosti polimiksin-sshitogo antilipopolisaharidnogo gemosorbenta v stendovyh opytah. In: Garelik PV, Karpickij AS, editors. Belorussko-polskie dni hirurgii. Sbornik materialov VI Mezhdunarodnogo nauchno-prakticheskogo simpoziuma; 2013 May 31; Grodno. Grodno: GrSMU; 2013. p. 36-38. (Russian).

Gapanovich VN, Kirkovsky VV, Tretiak DS, Golubovich VP, Kutsuk ON, Starostin AV, Melnova NI, Andreev SV. Antilipopolisaharidnyj gemosorbent na osnove sshitogo polimiksina [Antilipolisakharidny haemo sorbent on the basis of sewed polymyxin]. Voennaja medicina [Military Medicine]. 2013;(3):98-102. (Russian).

Kirkovsky VV, Dzyadzko AM, Gapanovich VN, Prilutsky PS, Ryabtseva TV. Izmenenie srednego arterialnogo davlenija i obshhego perifericheskogo soprotivlenija pri provedenii LPS-sorbcii u pacientov s septicheskim shokom v posleoperacionnom periode ortotopicheskoj transplantacii pecheni [Changing average blood pressure and general peripheral resistance under LPS sorption in patients with septic shock in postoperative period after orthotopic liver transplantation]. Zdravoohranenie. 2019;(5):51-55. (Russian).




Загрузок PDF: 248
Опубликован
2021-03-12
Как цитировать
1.
Якубцевич РЭ, Белявский НВ. ВОЗДЕЙСТВИЕ ЭКСТРАКОРПОРАЛЬНОЙ ГЕМОСОРБЦИИ НА ЭЛИМИНАЦИЮ АНТИБАКТЕРИАЛЬНЫХ ПРЕПАРАТОВ ПРИ СЕПСИСЕ. Журнал ГрГМУ (Journal GrSMU) [Интернет]. 12 март 2021 г. [цитируется по 24 ноябрь 2024 г.];19(1):10-5. доступно на: http://journal-grsmu.by/index.php/ojs/article/view/2418

Наиболее читаемые статьи этого автора (авторов)